Lexington, MA, United States of America

Svetlana E Korochkina

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Svetlana E Korochkina: Innovator in Immunotherapy

Introduction

Svetlana E Korochkina is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of immunotherapy, particularly through her innovative work on self-assembling vaccines. With a total of 2 patents, her research is paving the way for new therapeutic approaches in medicine.

Latest Patents

Korochkina's latest patents focus on immunotherapies employing self-assembling vaccines. These patents describe self-assembling pharmaceutical compositions that comprise a heat shock protein fused to a biotin-binding protein. The biotin-binding protein is non-covalently bound to four biotinylated components, with at least two of the four components being non-identical. This innovative approach has the potential to enhance the efficacy of vaccines and improve patient outcomes.

Career Highlights

Svetlana E Korochkina is affiliated with The General Hospital Corporation, where she continues to advance her research in immunotherapy. Her work is characterized by a commitment to developing novel therapeutic strategies that leverage the body's immune system to combat diseases.

Collaborations

Throughout her career, Korochkina has collaborated with esteemed colleagues, including Jeffrey A Gelfand and Mark C Poznansky. These collaborations have enriched her research and contributed to the advancement of immunotherapy.

Conclusion

Svetlana E Korochkina is a trailblazer in the field of immunotherapy, with her innovative patents and collaborative efforts driving significant advancements in medical science. Her work exemplifies the impact of dedicated research on improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…